idiopathic pulmonary hypertension |
Disease ID | 1231 |
---|---|
Disease | idiopathic pulmonary hypertension |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:5) C0018801 | heart failure | 2 C0856169 | endothelial dysfunction | 1 C0040038 | thromboembolism | 1 C0344706 | right atrial appendage aneurysm | 1 C1839611 | n syndrome | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:20) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs10744676 | 20556823 | 3741 | KCNA5 | umls:C0152171 | BeFree | Our results provide the first evidence for an association between the KCNA5 rs10744676 variant and PAH associated with SSc. | 0.001900093 | 2010 | KCNA5 | 12 | 5043783 | C | T |
rs137852741 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556360 | C | G,T |
rs137852741 | 21622843 | 659 | BMPR2 | umls:C0152171 | BeFree | Three BMPR2 mutants, D485G, N519K, and R899X, which are known to be involved in PAH, were chosen as our model system. | 0.15338735 | 2011 | BMPR2 | 2 | 202556360 | C | G,T |
rs137852742 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202464950 | C | G |
rs137852743 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202467625 | T | G |
rs137852744 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202530866 | G | A |
rs137852745 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552756 | A | G |
rs137852745 | 21622843 | 659 | BMPR2 | umls:C0152171 | BeFree | Three BMPR2 mutants, D485G, N519K, and R899X, which are known to be involved in PAH, were chosen as our model system. | 0.15338735 | 2011 | BMPR2 | 2 | 202552756 | A | G |
rs137852746 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552773 | C | T |
rs137852747 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202513807 | C | A |
rs137852748 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556282 | C | T |
rs137852749 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552774 | G | A |
rs137852750 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202467638 | T | A,C |
rs137852751 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202530820 | C | T |
rs137852752 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556361 | G | A,C |
rs137852752 | 15965979 | 659 | BMPR2 | umls:C3203102 | UNIPROT | BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. | 0.210314791 | 2005 | BMPR2 | 2 | 202556361 | G | A,C |
rs137852753 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202518831 | C | T |
rs344781 | 20967855 | 343170 | OR14K1 | umls:C0152171 | BeFree | In the Italian cohort, the rs344781 G allele was associated with SSc-related digital ulceration (odds ratio [OR] 1.39), pulmonary arterial hypertension (PAH) (OR 1.81), anticentromere antibody (ACA) positivity (OR 1.45), and limited cutaneous SSc (lcSSc) (OR 1.37). | 0.000271442 | 2011 | PLAUR | 19 | 43670636 | C | T |
rs483352902 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202377518 | C | - |
rs5743704 | 21905008 | 7097 | TLR2 | umls:C0152171 | BeFree | Among patients with SSc, the rare TLR2 Pro631His variant is robustly associated with antitopoisomerase positivity, the diffuse form of the disease, and the development of PAH. | 0.000271442 | 2012 | TLR2 | 4 | 153704799 | C | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |